Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Ominous Trends in Childhood Cancer Mortality: Who was Right?

McNally RJQ, James PW, Craft AW.

J Pediatr Hematol Oncol. 2017 Oct;39(7):577-578. doi: 10.1097/MPH.0000000000000913. No abstract available.

PMID:
28937521
2.

No Association between Radiation Dose from Pediatric CT Scans and Risk of Subsequent Hodgkin Lymphoma.

Berrington de Gonzalez A, Journy N, Lee C, Morton LM, Harbron RW, Stewart DR, Parker L, Craft AW, McHugh K, Little MP, Pearce MS.

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):804-806. doi: 10.1158/1055-9965.EPI-16-1011. Epub 2017 Jan 4.

3.

Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions.

Berrington de Gonzalez A, Salotti JA, McHugh K, Little MP, Harbron RW, Lee C, Ntowe E, Braganza MZ, Parker L, Rajaraman P, Stiller C, Stewart DR, Craft AW, Pearce MS.

Br J Cancer. 2016 Feb 16;114(4):388-94. doi: 10.1038/bjc.2015.415.

4.

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.

Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley MC, Kovar H, Grimer R, Whelan J, Claude L, Delattre O, Paulussen M, Picci P, Sundby Hall K, van den Berg H, Ladenstein R, Michon J, Hjorth L, Judson I, Luksch R, Bernstein ML, Marec-Bérard P, Brennan B, Craft AW, Womer RB, Juergens H, Oberlin O.

J Clin Oncol. 2015 Sep 20;33(27):3036-46. doi: 10.1200/JCO.2014.59.5256. Epub 2015 Aug 24. Review.

PMID:
26304893
5.

Response to: Comment on 'Updated investigations of cancer excesses in individuals born or resident in the vicinity of Sellafield and Dounreay'.

McNally RJ, Bunch KJ, Craft AW, Murphy MF.

Br J Cancer. 2015 May 26;112(11):1837. doi: 10.1038/bjc.2014.582. Epub 2014 Nov 20. No abstract available.

6.

Updated investigations of cancer excesses in individuals born or resident in the vicinity of Sellafield and Dounreay.

Bunch KJ, Vincent TJ, Black RJ, Pearce MS, McNally RJ, McKinney PA, Parker L, Craft AW, Murphy MF.

Br J Cancer. 2014 Oct 28;111(9):1814-23. doi: 10.1038/bjc.2014.357. Epub 2014 Jul 22.

7.

Socioeconomic patterning in the incidence and survival of children and young people diagnosed with malignant melanoma in northern England.

McNally RJQ, Basta NO, Errington S, James PW, Norman PD, Craft AW.

J Invest Dermatol. 2014 Nov;134(11):2703-2708. doi: 10.1038/jid.2014.246. Epub 2014 Jun 13.

8.

Survival from teenage and young adult cancer in Northern England, 1968-2008.

Basta NO, James PW, Gomez-Pozo B, Craft AW, Norman P, McNally RJ.

Pediatr Blood Cancer. 2014 May;61(5):901-6. doi: 10.1002/pbc.24939. Epub 2014 Jan 16.

9.

Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0-49-year-olds in Great Britain, 1980-2005.

Blakey K, Feltbower RG, Parslow RC, James PW, Gómez Pozo B, Stiller C, Vincent TJ, Norman P, McKinney PA, Murphy MF, Craft AW, McNally RJ.

Int J Epidemiol. 2014 Feb;43(1):224-34. doi: 10.1093/ije/dyt259. Epub 2014 Jan 14.

10.

CT Scans in Young People in Great Britain: Temporal and Descriptive Patterns, 1993-2002.

Pearce MS, Salotti JA, Howe NL, McHugh K, Kim KP, Lee C, Craft AW, Berrington de Gonzaléz A, Parker L.

Radiol Res Pract. 2012;2012:594278. doi: 10.1155/2012/594278. Epub 2012 Jun 26.

11.

Small-area analyses of bone cancer diagnosed in Great Britain provide clues to aetiology.

McNally RJ, Blakey K, Parslow RC, James PW, Pozo BG, Stiller C, Vincent TJ, Norman P, McKinney PA, Murphy MF, Craft AW, Feltbower RG.

BMC Cancer. 2012 Jun 27;12:270. doi: 10.1186/1471-2407-12-270.

12.

How the Newcastle Thousand Families birth cohort study has contributed to the understanding of the impact of birth weight and early life socioeconomic position on disease in later life.

Pearce MS, Mann KD, Relton CL, Francis RM, Steele JG, Craft AW, Parker L.

Maturitas. 2012 May;72(1):23-8. doi: 10.1016/j.maturitas.2012.02.005. Epub 2012 Mar 4. Review.

PMID:
22391388
13.

Socio-economic variation in CT scanning in Northern England, 1990-2002.

Pearce MS, Salotti JA, McHugh K, Kim KP, Craft AW, Lubin J, Ron E, Parker L.

BMC Health Serv Res. 2012 Jan 27;12:24. doi: 10.1186/1472-6963-12-24.

14.

Development of a database of organ doses for paediatric and young adult CT scans in the United Kingdom.

Kim KP, Berrington de González A, Pearce MS, Salotti JA, Parker L, McHugh K, Craft AW, Lee C.

Radiat Prot Dosimetry. 2012 Jul;150(4):415-26. doi: 10.1093/rpd/ncr429. Epub 2012 Jan 6.

15.

Seasonality in the incidence of cervical carcinoma in teenagers and young adults in Northern England, 1968-2005.

Basta NO, James PW, Craft AW, McNally RJ.

Chronobiol Int. 2011 Nov;28(9):819-24. doi: 10.3109/07420528.2011.611602.

PMID:
22080788
16.

Survival from childhood cancer in northern England, 1968-2005.

Basta NO, James PW, Gomez-Pozo B, Craft AW, McNally RJ.

Br J Cancer. 2011 Oct 25;105(9):1402-8. doi: 10.1038/bjc.2011.341. Epub 2011 Sep 20.

17.

CT scans in young people in Northern England: trends and patterns 1993-2002.

Pearce MS, Salotti JA, McHugh K, Metcalf W, Kim KP, Craft AW, Parker L, Ron E.

Pediatr Radiol. 2011 Jul;41(7):832-8. doi: 10.1007/s00247-011-2110-7. Epub 2011 May 19.

18.

Height at diagnosis and birth-weight as risk factors for osteosarcoma.

Mirabello L, Pfeiffer R, Murphy G, Daw NC, Patiño-Garcia A, Troisi RJ, Hoover RN, Douglass C, Schüz J, Craft AW, Savage SA.

Cancer Causes Control. 2011 Jun;22(6):899-908. doi: 10.1007/s10552-011-9763-2. Epub 2011 Apr 5.

19.

Seasonal variation in the month of birth in teenagers and young adults with melanoma suggests the involvement of early-life UV exposure.

Basta NO, James PW, Craft AW, McNally RJ.

Pigment Cell Melanoma Res. 2011 Feb;24(1):250-3. doi: 10.1111/j.1755-148X.2010.00791.x. Epub 2010 Nov 2. No abstract available.

PMID:
20955539
20.

Season of birth and diagnosis for childhood cancer in Northern England, 1968-2005.

Basta NO, James PW, Craft AW, McNally RJ.

Paediatr Perinat Epidemiol. 2010 May;24(3):309-18. doi: 10.1111/j.1365-3016.2010.01112.x.

PMID:
20415761
21.

Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose.

Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD.

Pediatr Blood Cancer. 2010 Jul 1;54(7):983-9. doi: 10.1002/pbc.22364.

PMID:
20405516
22.

Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.

Le Deley MC, Delattre O, Schaefer KL, Burchill SA, Koehler G, Hogendoorn PC, Lion T, Poremba C, Marandet J, Ballet S, Pierron G, Brownhill SC, Nesslböck M, Ranft A, Dirksen U, Oberlin O, Lewis IJ, Craft AW, Jürgens H, Kovar H.

J Clin Oncol. 2010 Apr 20;28(12):1982-8. doi: 10.1200/JCO.2009.23.3585. Epub 2010 Mar 22.

PMID:
20308673
23.

Osteosarcoma: the European Osteosarcoma Intergroup (EOI) perspective.

Craft AW.

Cancer Treat Res. 2009;152:263-74. doi: 10.1007/978-1-4419-0284-9_13. Review.

PMID:
20213395
24.

Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.

Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD.

Eur J Cancer. 2009 Dec;45(18):3213-9. doi: 10.1016/j.ejca.2009.06.032. Epub 2009 Oct 21.

PMID:
19850470
25.

Geographical analysis of thyroid cancer in young people from northern England: evidence for a sustained excess in females in Cumbria.

Magnanti BL, Dorak MT, Parker L, Craft AW, James PW, McNally RJ.

Eur J Cancer. 2009 Jun;45(9):1624-9. doi: 10.1016/j.ejca.2008.12.024. Epub 2009 Jan 27.

PMID:
19179067
26.

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.

Paulussen M, Craft AW, Lewis I, Hackshaw A, Douglas C, Dunst J, Schuck A, Winkelmann W, Köhler G, Poremba C, Zoubek A, Ladenstein R, van den Berg H, Hunold A, Cassoni A, Spooner D, Grimer R, Whelan J, McTiernan A, Jürgens H; European Intergroup Cooperative Ewing's Sarcoma Study-92.

J Clin Oncol. 2008 Sep 20;26(27):4385-93. doi: 10.1200/JCO.2008.16.5720.

PMID:
18802150
27.

Cohort profile: the Newcastle Thousand Families 1947 birth cohort.

Pearce MS, Unwin NC, Parker L, Craft AW.

Int J Epidemiol. 2009 Aug;38(4):932-7. doi: 10.1093/ije/dyn184. Epub 2008 Sep 9. No abstract available.

PMID:
18782900
28.

Sex-specific patterns and trends in the incidence of hematologic malignancies in 0-24 year olds from Northern England, 1968-2005.

Magnanti BL, Dorak MT, Parker L, Craft AW, James PW, McNally RJ.

Haematologica. 2008 Sep;93(9):1438-40. doi: 10.3324/haematol.12919. Epub 2008 Jul 4. No abstract available.

29.

Outcome and toxicity of an Ifosfamide-based soft tissue sarcoma treatment protocol in children. The importance of local therapy.

Yule SM, Skinner R, English MW, Cole M, Pearson AD, Lucraft HH, Craft AW.

Sarcoma. 1998;2(3-4):171-7. doi: 10.1080/13577149877939.

30.

Sex-specific incidence and temporal trends in solid tumours in young people from Northern England, 1968-2005.

Magnanti BL, Dorak MT, Parker L, Craft AW, James PW, McNally RJ.

BMC Cancer. 2008 Apr 3;8:89. doi: 10.1186/1471-2407-8-89.

31.

UK childhood cancer survival falling behind rest of EU?

Craft AW, Pritchard-Jones K.

Lancet Oncol. 2007 Aug;8(8):662-3. No abstract available.

PMID:
17679074
32.
33.

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, Hogendoorn PC, Memon MA, Weeden S, Uscinska BM, van Glabbeke M, Kirkpatrick A, Hauben EI, Craft AW, Taminiau AH; MRC BO06 and EORTC 80931 collaborators; European Osteosarcoma Intergroup.

J Natl Cancer Inst. 2007 Jan 17;99(2):112-28.

PMID:
17227995
34.

Relation between birth weight and soluble markers of endothelial function in middle aged subjects.

McIntyre EA, Parker L, Pearce MS, Gerrard J, Sattar N, Craft AW, Walker M.

Heart. 2006 May;92(5):679-80. No abstract available.

35.

Southall and colleagues vindicated once more.

Craft AW, McIntosh N.

Lancet. 2006 Apr 1;367(9516):1035-1037. doi: 10.1016/S0140-6736(06)68447-X. No abstract available.

PMID:
16581386
36.

Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.

Stiller CA, Passmore SJ, Kroll ME, Brownbill PA, Wallis JC, Craft AW.

Br J Cancer. 2006 Jan 16;94(1):22-9.

37.

Cancer in adolescents and young adults aged 15-24 years: a report from the North of England young person's malignant disease registry, UK.

Pearce MS, Parker L, Windebank KP, Cotterill SJ, Craft AW.

Pediatr Blood Cancer. 2005 Oct 15;45(5):687-93.

PMID:
16086423
38.

Second primary tumors in children and young adults in the North of England (1968-99).

Hammal DM, Bell CL, Craft AW, Parker L.

Pediatr Blood Cancer. 2005 Aug;45(2):155-61.

PMID:
15880357
40.

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study.

Nooij MA, Whelan J, Bramwell VH, Taminiau AT, Cannon S, Hogendoorn PC, Pringle J, Uscinska BM, Weeden S, Kirkpatrick A, Glabbeke Mv, Craft AW; European Osteosarcoma Intergroup.

Eur J Cancer. 2005 Jan;41(2):225-30.

PMID:
15661546
41.

Osteosarcoma: is big always worse?

Craft AW.

Pediatr Blood Cancer. 2004 Dec;43(7):713-4. No abstract available.

PMID:
15490490
42.

Detection of human respiratory syncytial virus genotype specific antibody responses in infants.

McGill A, Greensill J, Marsh R, Craft AW, Toms GL.

J Med Virol. 2004 Nov;74(3):492-8.

PMID:
15368511
43.

Establishing long-term survival and cure in young patients with Ewing's sarcoma.

Weston CL, Douglas C, Craft AW, Lewis IJ, Machin D.

Br J Cancer. 2004 Jul 19;91(2):225-32.

44.

Munchausen syndrome by proxy and sudden infant death.

Craft AW, Hall DM.

BMJ. 2004 May 29;328(7451):1309-12. Review. No abstract available.

45.

High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.

Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC.

Cancer. 2004 May 15;100(10):2222-32.

46.

Measurement of antibody against contemporary virus lineages of human respiratory syncytial virus sub-group A in infants and their mothers.

McGill A, Greensill J, Craft AW, Fenwick F, Toms GL.

J Clin Virol. 2004 May;30(1):73-80.

PMID:
15072758
47.

Stature of young people with malignant bone tumors.

Cotterill SJ, Wright CM, Pearce MS, Craft AW; UKCCSG/MRC Bone Tumour Working Group.

Pediatr Blood Cancer. 2004 Jan;42(1):59-63.

PMID:
14752796
48.

Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UK.

Pearce MS, Parker L, Cotterill SJ, Gordon PM, Craft AW.

Melanoma Res. 2003 Aug;13(4):421-6.

PMID:
12883370
49.

A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years.

Parker L, Lamont DW, Unwin N, Pearce MS, Bennett SM, Dickinson HO, White M, Mathers JC, Alberti KG, Craft AW.

Diabet Med. 2003 May;20(5):406-15. Erratum in: Diabet Med. 2003 Sep;20(9):781.

PMID:
12752491
50.

The national service framework for children.

Craft AW.

BMJ. 2003 Apr 26;326(7395):891-2. No abstract available.

Supplemental Content

Loading ...
Support Center